Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Can Help On Drug Prices – Except When It Can't, Califf Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Commissioner nominee tells Senate that faster approvals of cheap products and quicker development of innovative ones will reduce pricing pressure; 'monopoly' positions are a concern, but Califf draws the line when asked about drug importation.

You may also be interested in...



Califf Confirmation Hearing Round Two: Industry Ties Once Again May Bark Loud, Bite Lightly

The cardiologist seeking another term as FDA commissioner has been working in the pharma industry since leaving the post, but Senators have tended not to  question nominee's work history extensively during previous confirmation hearings.

Califf Confirmation Hearing Round Two: Industry Ties Once Again May Bark Loud, Bite Lightly

The cardiologist seeking another term as FDA commissioner has been working in the pharma industry since leaving the post, but Senators have tended not to  question nominee's work history extensively during previous confirmation hearings.

Rx Importation: Califf's Switch Means US FDA Commissioners No Longer Uniformly Opposed

In JAMA editorial, former FDA chief supports drug importation under narrow circumstances as a way to reduce drug prices, marking a shift from his previous stance on the issue and that of other past agency heads. Essay, co-authored by former CMS Acting Administrator Andy Slavitt, calls importation "a workaround born of desperation." 

Related Content

Topics

Related Companies

Latest News
UsernamePublicRestriction

Register

PS078000

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel